We were invited to the #EMAPublicMeeting and François Houÿez presented EURORDIS' take on the development and approval of the #covid19vaccines
EURORDIS trusts the high quality evaluation of the vaccines by the European Medicines Agency. People living with chronic and rare diseases should be among the first beneficiaries of the #COVID19Vaccine
Thank you very much to Emer Cooke for highlighting that the webinar was organised following a joint request by EURORDIS and European Patients' Forum
